Clinical Trial Update: Interleukin-2 in Treating Patients With Metastatic or Recurrent Kidney Cancer [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study of interleukin-2 in patients with metastatic or recurrent renal cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Interleukin-2 (interleukin-2)

Snippet

Sponsor: Blumenthal Cancer Center at Carolinas Medical Center | Conditions: Kidney Cancer | Phase 2 | Status: UNKNOWN